The store will not work correctly when cookies are disabled.
N1-(4-(4-methoxyphenyl)pyrimidin-2-yl)benzene-1,3-diamine
ID: ALA4098016
PubChem CID: 137661113
Max Phase: Preclinical
Molecular Formula: C17H16N4O
Molecular Weight: 292.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2ccnc(Nc3cccc(N)c3)n2)cc1
Standard InChI: InChI=1S/C17H16N4O/c1-22-15-7-5-12(6-8-15)16-9-10-19-17(21-16)20-14-4-2-3-13(18)11-14/h2-11H,18H2,1H3,(H,19,20,21)
Standard InChI Key: LTHCKHIXPOIYDD-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
10.2052 -10.5492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2041 -11.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9121 -11.7777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6218 -11.3682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6190 -10.5456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9103 -10.1403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9051 -9.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6132 -8.9158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6111 -8.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9016 -7.6921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1928 -8.1072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1984 -8.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8981 -6.8749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1886 -6.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3301 -11.7757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0372 -11.3660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7422 -11.7739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4488 -11.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4480 -10.5468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7346 -10.1395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0310 -10.5509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7305 -9.3223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
6 7 1 0
10 13 1 0
13 14 1 0
4 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 292.34 | Molecular Weight (Monoisotopic): 292.1324 | AlogP: 3.48 | #Rotatable Bonds: 4 |
Polar Surface Area: 73.06 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.48 | CX Basic pKa: 4.48 | CX LogP: 3.21 | CX LogD: 3.21 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.72 | Np Likeness Score: -1.19 |
References
1. Toviwek B, Suphakun P, Choowongkomon K, Hannongbua S, Gleeson MP.. (2017) Synthesis and evaluation of the NSCLC anti-cancer activity and physical properties of 4-aryl-N-phenylpyrimidin-2-amines., 27 (20): [PMID:28927795] [10.1016/j.bmcl.2017.08.063] |